References
- 1. Chamot AM, Benhamou CL, Kahn MF, Beraneck L, Kaplan G, Prost A. Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases. Rev Rhum Mal Osteoartic 1987;54(3):187-96.
- 2. Nguyen MT, Borchers A, Selmi C, Naguwa SM, Cheema G, Gershwin ME. The SAPHO Syndrome. Semin Arthritis Rheum 2012;42(3):254-65. doi: 10.1016/j.semarthrit.2012.05.006.
- 3. van Doornum S, Barraclough D, McColl G, Wicks I. SAPHO: Rare or just not recognized? Semin Arthritis Rheum 2000;30(1):70-7. doi: 10.1053/sarh.2000.8371.
- 4. Kerrison C, Davidson JE, Cleary AG, Beresford MW. Pamidronate in the treatment of childhood SAPHO syndrome. Rheumatology (Oxford) 2004;43(10):1246-51. doi: 10.1093/rheumatology/keh295.
- 5. Hayem G, Bouchaud-Chabot A, Benali K, Roux S, Palazzo E, Silbermann-Hoffman O, et al. SAPHO syndrome: A long-term follow-up study of 120 cases. Semin Arthritis Rheum 1999;29(3):159-71.
- 6. Assmann G, Simon P. The SAPHO syndrome – Are microbes involved? Best Pract Res Clin Rheumatol 2011;25(3):423-34. doi: 10.1016/j. berh.2011.01.017.
- 7. Earwaker JW, Cotten A. SAPHO: syndrome or concept? Imaging findings. Skeletal Radiol 2003;32(6):311-27. doi: 10.1007/s00256-003-0629-x.
- 8. Rukavina I. SAPHO syndrome: A review. J Child Orthop 2015;9(1):19-27. doi: 10.1007/s11832-014-0627-7.
- 9. Depasquale R, Kumar N, Lalam RK, Tins BJ, Tyrrell PN, Singh J, et al. SAPHO: What radiologists should know. Clin Radiol 2012;67(3):195-206. doi: 10.1016/j.crad.2011.08.014.
- 10. Quirico Rodríguez M, Casáns Tormo I, Redal Peña MC, Lopez Castillo V. The importance of bone scintigraphy in the diagnosis of sapho syndrome. Rev Esp Med Nucl Engl Ed 2010;29(3):127-30. doi: 10.1016/j.remn.2010.01.001.
- 11. Davies AM, Marino AJ, Evans N, Grimer RJ, Deshmukh N, Mangham DC. SAPHO syndrome: 20-year follow-up. Skeletal Radiol 1999;28(3): 159-62.
- 12. Sonozaki H, Mitsui H, Miyanaga Y, Okitsu K, Igarashi M, Hayashi Y, et al. Clinical features of 53 cases with pustulotic arthro-osteitis. Ann Rheum Dis 1981;40(6):547-53.
- 13. DiMeco F, Clatterbuck RE, Li KW, McCarthy EF, Olivi A. Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome presenting as a primary calvarial lesion. J Neurosurg 2000;93(4):693-7. doi: 10.3171/jns.2000.93.4.0693.
- 14. Khanna L, El-Khoury GY. SAPHO syndrome – A pictorial assay. Iowa Orthop J 2012;32:189-95.
- 15. Eyrich GK, Harder C, Sailer HF, Langenegger T, Bruder E, Michel BA. Primary chronic osteomyelitis associated with synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO syndrome). J Oral Pathol Med 1999;28(10):456-64.
- 16. Job-Deslandre C, Krebs S, Kahan A. Chronic recurrent multifocal osteomyelitis: Five-year outcomes in 14 pediatric cases. Joint Bone Spine 2001;68(3):245-51.
- 17. Arias-Santiago S, Sanchez-Cano D, Callejas-Rubio JL, Fernández-Pugnaire MA, Ortego-Centeno N. Adalimumab treatment for SAPHO syndrome. Acta Derm Venereol 2010;90(3):301-2. doi: 10.2340/00015555-0822.
- 18. Olivieri I, Padula A, Ciancio G, Salvarani C, Niccoli L, Cantini F. Successful treatment of SAPHO syndrome with infliximab: Report of two cases. Ann Rheum Dis 2002;61(4):375-6.
- 19. Vilar-Alejo J, Dehesa L, de la Rosa-del Rey P, Novoa-Medina J, Valerón Almazán PV, Medina NS, et al. SAPHO Syndrome with unusual cutaneous manifestations treated successfully with etanercept. Acta Derm Venereol 2010;90(5):531-2. doi: 10.2340/00015555-0895.
- 20. Massara A, Cavazzini PL, Trotta F. In SAPHO syndrome anti-TNF-α therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology (Oxford) 2006;45(6):730-3. doi: 10.1093/rheumatology/kei221.
- 21. Rozin AP, Nahir AM. Is SAPHO syndrome a target for antibiotic therapy? Clin Rheumatol 2007;26(5):817–20. doi: 10.1007/s10067-006-0274-6.